Furthermore, during the early phase of liver disease HO-1 function may alternatively affect regenerative proliferation in Mdr2−/− mice through interfering with Cyclin D1 expression up to 5 months after termination of treatment. This evidence concerns the gene CCND1 and liver disorder.